12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Thu, 17 Apr 2025 17:00:08 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => Cf-Ray: 931d7a122d89f789-DFW [10] => X-Frame-Options: SAMEORIGIN [11] => X-Xss-Protection: 1; mode=block [12] => X-Content-Type-Options: nosniff [13] => Referrer-Policy: no-referrer-when-downgrade [14] => Cf-Cache-Status: DYNAMIC [15] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=0yZlfQD0uWGhjzBDqYA0u4m7F8O%2BST397IickfV67jxKCdYc6E1SLppmRVx5CfJ7vSRS6DAi63OvDIrFAc3HZXbgCv0WWqieC7RouQdJ0IA%2B%2BkmkG5kNEM%2FuDti7PwPlwzI%3D"}],"group":"cf-nel","max_age":604800} [16] => Set-Cookie: UpalLiveSession=eyJpdiI6IlE4cHI0bjhwUHRrMHJ3XC9uNk5uUGN3PT0iLCJ2YWx1ZSI6Ik40NnRCVWV5dHBMSVNsWXoyNlhKelhyOFd1amsrbU96bDFuZVwvallObzFidnA0aVwvMVdnRXNWYUYwellBckxzV01BcnJIeFNjTmk3a0ZiRXVta2xRVFE9PSIsIm1hYyI6IjM5OGNlMDk2NDYxYmZkYTgyOWJhMDA2YmVmNDNkZWE5ZjY2ZGIyZDliZTY0N2I5YzU5ZTVkNTg1ZjJmYmRhMGIifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Sun, 16 Apr 2028 16:20:05 GMT [17] => alt-svc: h3=":443"; ma=86400 [18] => server-timing: cfL4;desc="?proto=TCP&rtt=218784&min_rtt=218692&rtt_var=61612&sent=5&recv=6&lost=0&retrans=0&sent_bytes=3000&recv_bytes=756&delivery_rate=13242&cwnd=33&unsent_bytes=0&cid=5e234f62e6a6e4d0&ts=1136&x=0" ) 789

中国研发的新型冠状病毒核酸检测试剂盒，已于28日通过中国国家药品监督管理局审批，获得医疗器械注册证书。

这个新测试剂盒宣称可在30分钟内获得结果，大幅缩短检测时间，可以让疫情疑似病例，尤其是没有病症的隐性感染者得到快速分流，有效防止疫情扩散。

这项产品由中国圣湘生物科技公司推出，中国体外检测诊断领域专家戴立忠主导的应急技术攻关小组研发，采用“RNA一步法”技术，适用于不同场景，操作简单，检测耗时短，再搭配圣湘生物自主研发的全自动核酸提取仪、移动分子诊断平台，能实现1人1机1日检测样本量达1000人份以上的高通量检测，最快可在30分钟出检测结果，实现现场即时检测。

---

// // // //